ProfileGDS4718 / 1558467_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 34% 22% 35% 31% 39% 42% 29% 38% 36% 34% 42% 48% 56% 45% 34% 23% 46% 43% 60% 23% 33% 35% 37% 41% 45% 50% 72% 40% 48% 37% 45% 29% 34% 51% 47% 38% 34% 30% 29% 33% 51% 39% 48% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.895338
GSM549102patient 115, normal, homogenized [OPG study]4.7479234
GSM549104patient 119, normal, homogenized [OPG study]4.2000322
GSM549108patient 138, normal, homogenized [OPG study]4.7958735
GSM549119patient 077, normal, homogenized [OPG study]4.6069831
GSM549133patient 032, cancer, homogenized [OPG study]4.880639
GSM549139patient 042, cancer, homogenized [OPG study]5.0577942
GSM549099patient 107, normal, homogenized [OPG study]4.5126929
GSM549109patient 139, normal, homogenized [OPG study]4.9199938
GSM549110patient 046, normal, homogenized [OPG study]4.8224436
GSM549114patient 063, normal, homogenized [OPG study]4.6871534
GSM549122patient 082, normal, homogenized [OPG study]5.0720842
GSM549134patient 033, cancer, homogenized [OPG study]5.3756248
GSM549136patient 036, cancer, homogenized [OPG study]5.8274856
GSM549140patient 044, cancer, homogenized [OPG study]5.2260545
GSM549111patient 047, normal, homogenized [OPG study]4.6774934
GSM549113patient 057, normal, homogenized [OPG study]4.1984123
GSM549132patient 031, cancer, homogenized [OPG study]5.2933646
GSM549137patient 038, cancer, homogenized [OPG study]5.1362943
GSM549142patient 047, cancer, homogenized [OPG study]6.2177160
GSM549100patient 110, normal, homogenized [OPG study]4.2560223
GSM549107patient 135, normal, homogenized [OPG study]4.6574233
GSM549115patient 068, normal, homogenized [OPG study]4.7105835
GSM549116patient 072, normal, homogenized [OPG study]4.8109737
GSM549120patient 078, normal, homogenized [OPG study]5.0597341
GSM549131patient 030, cancer, homogenized [OPG study]5.2003645
GSM549118patient 074, normal, homogenized [OPG study]5.5010750
GSM549129patient 027, cancer, homogenized [OPG study]7.1233372
GSM549123patient 088, normal, homogenized [OPG study]4.9543940
GSM549124patient 006, cancer, homogenized [OPG study]5.4393148
GSM549126patient 015, cancer, homogenized [OPG study]4.8271737
GSM549128patient 025, cancer, homogenized [OPG study]5.2363645
GSM549103patient 117, normal, homogenized [OPG study]4.5491429
GSM549117patient 073, normal, homogenized [OPG study]4.678734
GSM549138patient 041, cancer, homogenized [OPG study]5.5621451
GSM549141patient 045, cancer, homogenized [OPG study]5.2804947
GSM549130patient 028, cancer, homogenized [OPG study]4.88338
GSM549101patient 111, normal, homogenized [OPG study]4.745234
GSM549105patient 128, normal, homogenized [OPG study]4.5601430
GSM549106patient 134, normal, homogenized [OPG study]4.4317129
GSM549112patient 048, normal, homogenized [OPG study]4.6799433
GSM549125patient 011, cancer, homogenized [OPG study]5.5601551
GSM549127patient 024, cancer, homogenized [OPG study]4.9607139
GSM549135patient 035, cancer, homogenized [OPG study]5.3773848